Logo image of CZOO

CAZOO GROUP LTD (CZOO) Stock Fundamental Analysis

NYSE:CZOO - New York Stock Exchange, Inc. - KYG2007L1216 - Common Stock - Currency: USD

6.04  +0.01 (+0.17%)

Premarket: 5.88 -0.16 (-2.65%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CZOO. CZOO was compared to 121 industry peers in the Specialty Retail industry. CZOO has a bad profitability rating. Also its financial health evaluation is rather negative. CZOO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CZOO has reported negative net income.
CZOO had a positive operating cash flow in the past year.
CZOO had negative earnings in each of the past 5 years.
CZOO had a negative operating cash flow in each of the past 5 years.
CZOO Yearly Net Income VS EBIT VS OCF VS FCFCZOO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 -200M -400M -600M

1.2 Ratios

With a Return On Assets value of -133.24%, CZOO is not doing good in the industry: 97.60% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -133.24%
ROE N/A
ROIC N/A
ROA(3y)-49.23%
ROA(5y)-33.04%
ROE(3y)-359.04%
ROE(5y)-221.21%
ROIC(3y)N/A
ROIC(5y)N/A
CZOO Yearly ROA, ROE, ROICCZOO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 -200 -400 -600 -800

1.3 Margins

The Gross Margin of CZOO (1.63%) is worse than 96.80% of its industry peers.
The Profit Margin and Operating Margin are not available for CZOO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CZOO Yearly Profit, Operating, Gross MarginsCZOO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 -500 -1K

More info and screens

3

2. Health

2.1 Basic Checks

CZOO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CZOO has been increased compared to 1 year ago.
Compared to 1 year ago, CZOO has a worse debt to assets ratio.
CZOO Yearly Shares OutstandingCZOO Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 10M 20M 30M
CZOO Yearly Total Debt VS Total AssetsCZOO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.2 Solvency

CZOO has an Altman-Z score of -2.09. This is a bad value and indicates that CZOO is not financially healthy and even has some risk of bankruptcy.
CZOO's Altman-Z score of -2.09 is on the low side compared to the rest of the industry. CZOO is outperformed by 88.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.09
ROIC/WACCN/A
WACC3.66%
CZOO Yearly LT Debt VS Equity VS FCFCZOO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 200M -200M 400M -400M 600M -600M

2.3 Liquidity

CZOO has a Current Ratio of 2.12. This indicates that CZOO is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CZOO (2.12) is better than 81.60% of its industry peers.
A Quick Ratio of 1.34 indicates that CZOO should not have too much problems paying its short term obligations.
The Quick ratio of CZOO (1.34) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.34
CZOO Yearly Current Assets VS Current LiabilitesCZOO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

CZOO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.52%.
Looking at the last year, CZOO shows a very strong growth in Revenue. The Revenue has grown by 90.51%.
Measured over the past years, CZOO shows a very strong growth in Revenue. The Revenue has been growing by 913.32% on average per year.
EPS 1Y (TTM)-13.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.68%
Revenue 1Y (TTM)90.51%
Revenue growth 3Y913.32%
Revenue growth 5YN/A
Sales Q2Q%-70.68%

3.2 Future

CZOO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.88% yearly.
The Revenue is expected to grow by 1.22% on average over the next years.
EPS Next Y63.5%
EPS Next 2Y33.6%
EPS Next 3Y23.88%
EPS Next 5YN/A
Revenue Next Year-35.48%
Revenue Next 2Y-10.27%
Revenue Next 3Y1.22%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CZOO Yearly Revenue VS EstimatesCZOO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CZOO Yearly EPS VS EstimatesCZOO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -200 -400 -600 -800

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CZOO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CZOO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CZOO Price Earnings VS Forward Price EarningsCZOO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CZOO Per share dataCZOO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 -100 200 -200 300

4.3 Compensation for Growth

CZOO's earnings are expected to grow with 23.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.6%
EPS Next 3Y23.88%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CZOO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAZOO GROUP LTD

NYSE:CZOO (5/20/2024, 8:04:00 PM)

Premarket: 5.88 -0.16 (-2.65%)

6.04

+0.01 (+0.17%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)10-25 2023-10-25/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap29.54M
Analysts43.33
Price Target171.67 (2742.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-7.22%
Min Revenue beat(2)-15.75%
Max Revenue beat(2)1.32%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-37.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF 2.62
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-23.48
EYN/A
EPS(NY)-264.98
Fwd EYN/A
FCF(TTM)-3.75
FCFYN/A
OCF(TTM)2.3
OCFY38.13%
SpS324.6
BVpS-20.28
TBVpS-24.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -133.24%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.63%
FCFM N/A
ROA(3y)-49.23%
ROA(5y)-33.04%
ROE(3y)-359.04%
ROE(5y)-221.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.36
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.19%
Cap/Sales 1.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 1.34
Altman-Z -2.09
F-Score3
WACC3.66%
ROIC/WACCN/A
Cap/Depr(3y)77.64%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.68%
EPS Next Y63.5%
EPS Next 2Y33.6%
EPS Next 3Y23.88%
EPS Next 5YN/A
Revenue 1Y (TTM)90.51%
Revenue growth 3Y913.32%
Revenue growth 5YN/A
Sales Q2Q%-70.68%
Revenue Next Year-35.48%
Revenue Next 2Y-10.27%
Revenue Next 3Y1.22%
Revenue Next 5YN/A
EBIT growth 1Y-33.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.65%
EBIT Next 3Y26.41%
EBIT Next 5YN/A
FCF growth 1Y92.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.32%
OCF growth 3YN/A
OCF growth 5YN/A